Reviva Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

Published on 11/13/2026 at 06:20 am EST – Modified on 11/13/2026 at 06:35 am EST S&P Capital IQ Reviva Pharmaceuticals Holdings, Inc. reported earnings results for the third quarter and nine months ended September 30, 2026. For the third quarter, the company reported net loss was USD 2.3 million compared to USD 4.01 million a…

Read Full News

The US Venture Capital Market and AI Investment Growth

The US venture capital market is witnessing a shift in investment priorities, with artificial intelligence leading the way while deep tech, fintech, biotechnology, clean energy and advanced manufacturing create new opportunities for startups. As investors become more selective, businesses with practical solutions, strong revenue potential and sustainable growth models are gaining importance. The United States…

Read Full News

FATF Targets Major Crypto Markets in Global Anti-Money Laundering Compliance Review – BitKE

The Financial Action Task Force (FATF) is launching a targeted review of jurisdictions with significant cryptocurrency activity to address gaps in the implementation and enforcement of global anti-money laundering standards.   The review will focus on jurisdictions with materially important virtual asset service provider (VASP) activity taking their existing regulatory assessment status into account. The…

Read Full News

‘Looks like we’ll have to talk to people’: Australia sent back to time before email with major Microsoft outage | Microsoft

Australian schools, courts and government services have been hurled back in time to how business used to be done after a global Microsoft outage caused emails and online meetings to go dark. Australians began reporting issues with Microsoft 365 – which includes Outlook and Teams – just before 5am AEST on Friday, according to Down…

Read Full News